$ cat ./records/committed-168-million-across-three-malaria-research-grants-trigge-2003.txt
Committed $168 million across three malaria research grants — triggering a sixfold rise in global malaria funding
[RECORD.TXT] · cat --full
The Gates Foundation committed $168 million across three concentrated malaria research grants covering vaccine development, new drug candidates, and innovative mosquito control. The investment helped catalyse a near-sixfold increase in global malaria funding over the decade that followed — with malaria cases and deaths beginning to fall substantially from 2005 onward for the first time in decades. Researchers credited the influx of private philanthropic capital with re-energising a field that had been chronically underfunded relative to its disease burden.
Source: https://www.gatesfoundation.org/ideas/media-center/press-releases/2003/09/funding-malaria-research
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Funds HarvestPlus to Breed Biofortified Staple Crops for Developing Countries
Next →
Cascade Investment Begins Quietly Acquiring US Farmland Through Washington State and the Pacific Northwest
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.